Squamous cell carcinoma of the eyelid.
Jpn J Clin Oncol
; 54(1): 4-12, 2024 Jan 07.
Article
in En
| MEDLINE
| ID: mdl-37747408
ABSTRACT
Eyelid squamous cell carcinoma is a major type of rare eyelid cancer, together with basal cell carcinoma and sebaceous gland carcinoma. It is a painless disease that progresses slowly and is often detected by the appearance of nodules or plaques. Risk factors include exposure to ultraviolet light, fair skin, radiation and human papillomavirus infection. The standard treatment is surgical removal, and in cases of orbital invasion, orbital content removal is required. If sentinel node biopsy reveals a high risk of lymph node metastasis, adjuvant radiotherapy may be considered. Local chemotherapy, such as imiquimod and 5-fluorouracil, may be used for eyelid squamous cell carcinoma in situ. When surgery or radiotherapy is not recommended for distant metastases or locally advanced disease, drug therapy is often according to head and neck squamous cell carcinoma in Japan. The treatment often requires a multidisciplinary team to ensure the preservation of function and cosmetic appearance.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Carcinoma, Squamous Cell
/
Eyelid Neoplasms
/
Head and Neck Neoplasms
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Jpn J Clin Oncol
Year:
2024
Document type:
Article
Affiliation country: